IONS

Latest SEC Filings & News for IONS

2 most recent filings and news items mentioning IONS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/IONS/news?limit=20"

Pull IONS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

LeadershipJun 8, 2026Positive

Ionis appoints Ludwig Hantson, biopharmaceutical executive, to Board of Directors

Ionis Pharmaceuticals announced the appointment of Ludwig Hantson, Ph.D., a veteran biopharma executive with 30+ years of experience including CEO roles at Alexion and Baxalta, to its Board of Directors effective immediately. The appointment strengthens board expertise as Ionis p

View filing at SEC.gov →

RegulatoryMay 28, 2026Positive

GSK's bepirovirsen achieves 19% functional cure rate in chronic hepatitis B trials

GSK announced positive Phase 3 pivotal data for bepirovirsen, Ionis's antisense oligonucleotide, showing a 19% functional cure rate versus 0% with standard of care in chronic hepatitis B patients. The results represent significant commercial potential for Ionis through its partne

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.